MedPath

Comparison of Obturator Nerve Block With Ultrasound Guidance and Anatomical Signs

Not Applicable
Conditions
Succesful Obturator Nerve Block
Bladder Tumor
Bleeding
Interventions
Procedure: obturator nerve block
Registration Number
NCT04638569
Lead Sponsor
Muğla Sıtkı Koçman University
Brief Summary

Comparison of the obturator nerve block in patients undergoing transurethral resection due to bladder tumor, technically using ultrasound guided or blinded with anatomical signs.

Detailed Description

The primary aim of this study is to compare the success rates of ONB techniques performed with ultrasound guided or blind technique. Its secondary purpose is to compare the effect of peroperative bleeding and control cystoscopy performed in the postoperative 3rd month on the presence of recurrent tumor.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
116
Inclusion Criteria
  • ASA I-II patients
Exclusion Criteria
  • Tumors that disrupt the integrity of the bladder,
  • bladder floor tumors,
  • coagulation disorders,
  • motor in the lower limbs
  • with sensory disturbances,
  • uncooperative patients,
  • Known allergy to local anesthetics
  • patients with localized infection at the procedure site

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
obtutaror nerve block with anatomical landmarksobturator nerve blockIn the second group, after the patient is placed in the lithotomy position, 1.5 cm lateral tuberculum pubis and 1.5 cm caudal will be marked and needle entry will be made and 0.5% bupivacaine will be injected with 10 mL.
Ultrasound-guided obturator nerve block groupobturator nerve blockThe ultrasound probe will be placed in the middle of the tuberculum pubis and femoral artery, 5-6 cm below the inguinal ligament, and 5 mL of 0.5% bupivacaine will be injected into the anterior and posterior branches of the ON with a needle.
Primary Outcome Measures
NameTimeMethod
Preoperative succesful obturator nerve blockoperation time

peroperative adductor muscle spazm

Secondary Outcome Measures
NameTimeMethod
peroperative bleeding, Presence of recurrent tumor at postoperative 3rd month3 months

peroperative bledding, Control by cystoscopy in the postoperative 3rd month recurrence tumor size

Trial Locations

Locations (1)

Mugla Sitki Kocman University

🇹🇷

Mugla, Turkey

© Copyright 2025. All Rights Reserved by MedPath